Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDICT: Prazosin for PTSD in Veterans
NCT03539614Phase 3Active, not recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Jun 2018
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prazosin in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Jun 2018; status: active, not recruiting.
02
Drugs
prazosin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03539614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03539614.